Venous thromboembolism (VTE) prevention program implementation in a community oncology practice: author response to Yang et al

Venous thromboembolism (VTE) prevention program implementation in a community oncology practice: author response to Yang et al

Saved in:

Bibliographic Details
Main Authors:	Steven Ades, Chris Holmes
Format:	Article
Language:	English
Published:	Elsevier 2025-02-01
Series:	The Lancet Regional Health. Americas
Online Access:	http://www.sciencedirect.com/science/article/pii/S2667193X24003077
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

SECONDARY PROPHYLAXIS OF VENOUS THROMBOEMBOLISM (VTE) WITH LOW DOSE APIXABAN OR RIVAROXABAN: RESULTS FROM A PATIENT POPULATION WITH MORE THAN 2 YEARS OF MEDIAN FOLLOW-UP
by: Alessandro Laganà, et al.
Published: (2024-02-01)

Strategies for Diagnosis and Prevention of Venous Thromboembolism during Pregnancy
by: Shalini Jain Bagaria, et al.
Published: (2011-01-01)

Arterial Thromboembolism in Patients With Advanced Lung Cancer: Secondary Analyses of the Rising‐VTE/NEJ037 Study
by: Naoki Furuya, et al.
Published: (2025-01-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Julien Succar, et al.
Published: (2011-05-01)

THALASSEMIA AND VENOUS THROMBOEMBOLISM
by: Khaled M. Musallam, et al.
Published: (2011-01-01)

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
by: Michele Bibas, et al.
Published: (2011-07-01)

HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
by: Michele Bibas, et al.
Published: (2011-01-01)

Venous thromboembolic events: case history
by: T.V. Shelkovnikova, et al.
Published: (2019-11-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-01-01)

SICKLE CELL DISEASE AND VENOUS THROMBOEMBOLISM
by: Zohreh Rahimi, et al.
Published: (2011-05-01)

Risk assessment and prevention of cancer-associated venous thromboembolism in ambulatory patients with solid malignancies
by: Nikola Vladic, et al.
Published: (2025-01-01)

Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Maria I. Zervou, et al.
Published: (2025-02-01)

PERIOPERATIVE PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ROUTINE ONCOSURGERY
by: V. E. Khoronenko, et al.
Published: (2016-12-01)

Venous thromboembolism still leads on maternal death
by: Amelia Shard, et al.
Published: (2025-01-01)

Intermittent pneumatic compression for venous thromboembolism prevention: a systematic review on factors affecting adherence
by: Richard Greenall, et al.
Published: (2020-09-01)

Response to Comment on: Multimorbidity, comorbidity, frailty, and venous thromboembolism
by: Bengt Zöller, et al.
Published: (2025-02-01)

Current Status of New Anticoagulants in the Management of Venous Thromboembolism
by: Roberto C. Montoya, et al.
Published: (2012-01-01)

Anticoagulation in venous thromboembolism in Behçet’s syndrome: friend or foe?
by: Rosaria Talarico, et al.
Published: (2024-12-01)

Acute Cytomegalovirus infection as a cause of venous thromboembolism
by: Raffaella Lissandrin, et al.
Published: (2014-05-01)

Racial disparities in extended venous thromboembolism prophylaxis after hysterectomy.
by: Wenbo Wu, et al.
Published: (2025-01-01)

Biological Aging and Venous Thromboembolism: A Review of Telomeres and Beyond
by: Rafaela Vostatek, et al.
Published: (2024-12-01)

Causal relationship between educational attainment and the occurrence of venous thromboembolism
by: Sitong Guo, et al.
Published: (2025-02-01)

Survey of Perceptions and Practices among Canadian Gastroenterologists regarding the Prevention of Venous Thromboembolism for Hospitalized Inflammatory Bowel Disease Patients
by: Roshan Razik, et al.
Published: (2012-01-01)

Venous thromboembolism in bullous pemphigoid: current evidence and update on systematic review
by: Atheer G. Almutairi, et al.
Published: (2025-01-01)

VTE prophylaxis administration in trauma patients: we are still behind the eight ball
by: Amanda L Teichman, et al.
Published: (2024-09-01)

Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
by: Marte Svalastoga, et al.
Published: (2025-01-01)

Enhancing Venous Thromboembolism Risk Prediction through Novel Biomarkers and Inflammatory Indicators
by: Zainab Wahab Al-Maaroof
Published: (2024-12-01)

A nomogram predicting the risk of venous thromboembolism in patients following urologic surgeries
by: Mengchao Wei, et al.
Published: (2025-01-01)

RISK FACTORS FOR THE DEVELOPMENT OF VENOUS THROMBOEMBOLISM IN PATIENTS WITH UNCOMPLICATED ACUTE CALCULOUS CHOLECYSTITIS
by: Mariya Kavka
Published: (2023-10-01)

Investigation of the Frequency of Thrombophilic Gene Mutations in Patients with Venous Thromboembolism in Eastern Turkey
by: Abdulgani Tatar, et al.
Published: (2023-06-01)

A new risk assessment model of venous thromboembolism by considering fuzzy population
by: Xin Wang, et al.
Published: (2024-12-01)

The need for speed: time to first venous thromboembolism prophylaxis in trauma patients matters
by: Allison E Berndtson, et al.
Published: (2024-09-01)

THE NATIONAL ONCOLOGICAL PROGRAM IMPLEMENTATION – EXPERIENCE IN THE VLADIMIR REGION (TO THE 70TH ANNIVERSARY OF THE REGIONAL CLINICAL ONCOLOGICAL DISPENSARY)
by: A. G. Zirin, et al.
Published: (2017-03-01)

Evaluation of Risk Factors of Venous Thromboembolism in Imam Sadiq Teaching Hospital at Babylon City
by: Intisar Mahdi Kadhim Almurshedi, et al.
Published: (2022-11-01)

Evaluating chemical venous thromboembolism prophylaxis in trauma patients at a single Australian center
by: Natalie Quarmby, et al.
Published: (2024-09-01)

Risk of Venous Thromboembolism in Patients Nursed at Home or in Long-Term Care Residential Facilities
by: Guido Arpaia, et al.
Published: (2011-01-01)

Janus kinase inhibitor treatment for inflammatory diseases: excess or no excess risk of venous thromboembolism?
by: Yachar Dawudi, et al.
Published: (2025-01-01)

Multimorbidity is associated with risk of incident venous thromboembolism – A nationwide proof-of-concept study
by: Jonatan Ahrén, et al.
Published: (2025-03-01)

Circulating, Extracellular Vesicle-Associated Tissue Factor in Cancer Patients with and without Venous Thromboembolism
by: Valentina Lami, et al.
Published: (2025-01-01)

Evaluation of Rivaroxaban Exposure via Anti-Xa Levels During VTE Prophylaxis in Hospitalized Patients
by: Kaitlin Blotske PharmD, et al.
Published: (2025-02-01)